Kaya Holdings (KAYS) Net Cash Flow Growth (3y) (2014 - 2025)
Kaya Holdings (KAYS) Net Cash Flow Growth (3y) (2014 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 32.03% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 28.99% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -49.94% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -41.05% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -62.71% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -205.66% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -59.10% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 36.11% |
| 10 | Kaya Holdings | - | - | 5,370.00 | 37.31% |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 37.31% |
| Jun 30, 2025 | 74.57% |
| Mar 31, 2025 | 26.65% |
| Dec 31, 2024 | -29.11% |
| Sep 30, 2024 | 119.17% |
| Jun 30, 2024 | -66.89% |
| Mar 31, 2024 | 56.41% |
| Dec 31, 2023 | -137.05% |
| Sep 30, 2023 | -152.24% |
| Jun 30, 2023 | 108.64% |
| Mar 31, 2023 | 39.08% |
| Dec 31, 2022 | -30.26% |
| Sep 30, 2022 | -16.73% |
| Jun 30, 2022 | -336.95% |
| Mar 31, 2022 | -440.93% |
| Dec 31, 2021 | 65.10% |
| Sep 30, 2021 | -29.88% |
| Jun 30, 2021 | 33.14% |
| Mar 31, 2021 | 34.65% |
| Dec 31, 2020 | -23.48% |